A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
NCT01568398 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2014-02-10
Summary
The purpose of this study is to study the safety and efficacy of TAK-438, once daily (QD), in participants with a history of gastric or duodenal ulcer requiring long-term low-dose aspirin therapy will be investigated.
Conditions
- Gastric Ulcer
- Duodenal Ulcer
Interventions
- DRUG
-
TAK-438
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- Japan
Study Locations
More Related Trials
-
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer
NCT01452711 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer
NCT01452724 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium Capsules LDA Specific Clinical Experience Investigation
NCT01729182 ·Status: COMPLETED
-
Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
NCT01069939 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects
NCT02141698 ·Status: COMPLETED ·Phase: PHASE1
-
Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"
NCT03214094 ·Status: COMPLETED
-
A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis
NCT01630746 ·Status: COMPLETED ·Phase: PHASE3
-
Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"
NCT03214198 ·Status: COMPLETED
-
Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
NCT02099682 ·Status: COMPLETED
-
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
NCT03050359 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
NCT02099708 ·Status: COMPLETED
-
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
NCT03050307 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers
NCT01353144 ·Status: COMPLETED ·Phase: PHASE4
-
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation
NCT01051388 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
NCT00762359 ·Status: TERMINATED ·Phase: PHASE3
-
Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation
NCT01562600 ·Status: COMPLETED
-
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
NCT02423187 ·Status: COMPLETED
-
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
NCT01397448 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
NCT00595517 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
NCT02153398 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium Capsules Clinical Experience Investigation
NCT01434485 ·Status: COMPLETED
-
Ulcer Prevention II
NCT00629928 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID
NCT00542789 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
NCT00960869 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
NCT01398410 ·Status: COMPLETED ·Phase: PHASE2/PHASE3